Patents Assigned to HUBEI UNIVERSITY OF TECHNOLOGY
  • Publication number: 20160289242
    Abstract: The present invention discloses an anilino-substituted podophyllin derivative having antitumor activity, method for preparation thereof, and use thereof. By means of anilino reactions, the present invention introduces 4-chloro-3-methylaniline, 3-fluoro-4-methoxyaniline, 4,4?-diaminodiphenylmethane, o-anisidine, 4-chloro-2-aminoanisole, anthranilonitrile, 2,6-dichloro-4-aminophenol, N,N-dimethylamino meta-aniline, 2-ethyl-5-nitroaniline, 2 2?-diaminodiphenylsulfide, or 2-aminobenzotrifluoride into position 4 of the active C-ring of podophyllotoxin or 4?-demethylepipodophyllotoxin to obtain the aniline-substituted podophyllotoxin derivative shown in formula (V); by means of multi-pathway and multi-target effects on tumor cells, said derivative has significantly increased antitumor activity, and can be prepared as an antineoplastic drug and applied in clinical antitumor therapy.
    Type: Application
    Filed: September 5, 2014
    Publication date: October 6, 2016
    Applicant: HUBEI UNIVERSITY OF TECHNOLOGY
    Inventors: Yajie TANG, Yong YANG, Wei ZHAO, Hongmei LI
  • Publication number: 20160264592
    Abstract: The present invention discloses a sulfur-substituted podophyllotoxin derivative, synthesis method thereof, and use thereof. The present invention introduces a rigid aromatic heterocyclic compound, as well as a further sulfonamidated product of 3-amino-5-mercapto-1,2,4-triazole, 2-amino-5-mercapto-1,3,4-thiadiazole, 4-methylbenzenesulfonyl chloride, or 4-methoxybenzenesulfonyl chloride as a substituent group, into position 4 of the C-ring of podophyllotoxin or 4?-demethylepipodophyllotoxin to obtain the podophyllotoxin derivative shown in formula (V), said derivative having significantly increased antitumor activity and reduced toxic side effects. Experiments on in vitro tumor cell inhibition indicate that the antitumor activity of the compound of formula (V) of the present invention is significantly higher than the antitumor activity of podophyllotoxin or 4?-demethylepipodophyllotoxin.
    Type: Application
    Filed: September 5, 2014
    Publication date: September 15, 2016
    Applicant: HUBEI UNIVERSITY OF TECHNOLOGY
    Inventors: Yajie TANG, Jianlong LI, Wei ZHAO, Hongmei LI
  • Patent number: 8796279
    Abstract: A 4?-demethylepipodophyllotoxin derivative of formula (III) having anti-tumor activity is provided. After the activation of hydroxyl in position C4 of 4?-demethylepipodophyllotoxin, tetramethylpyrazine is introduced by transamination to obtain the 4?-demethylepipodophyllotoxin derivative which is preferably used to inhibit gastric cancer line BGC-823.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: August 5, 2014
    Assignee: Hubei University of Technology
    Inventors: Ya-Jie Tang, Wei Zhao
  • Publication number: 20140024831
    Abstract: A 4?-demethylepipodophyllotoxin derivative of formula(III) having anti-tumor activity is provided. After the activation of hydroxyl in position C4 of 4?-demethylepipodophyllotoxin, tetramethylpyrazine is introduced by transamination to obtain the 4?-demethylepipodophyllotoxin derivative which is preferably used to inhibit gastric cancer line BGC-823.
    Type: Application
    Filed: September 25, 2013
    Publication date: January 23, 2014
    Applicant: Hubei University of Technology
    Inventor: YaJie Tang
  • Patent number: 8569309
    Abstract: A 4?-demethylepipodophyllotoxin derivative of formula(III) having anti-tumor activity is provided. After the activation of hydroxyl in position C4 of 4?-demethylepipodophyllotoxin, tetramethylpyrazine is introduced by transamination to obtain the 4?-demethylepipodophyllotoxin derivative which is preferably used to inhibit gastric cancer line BGC-823.
    Type: Grant
    Filed: April 22, 2011
    Date of Patent: October 29, 2013
    Assignee: Hubei University of Technology
    Inventor: YaJie Tang
  • Publication number: 20130040967
    Abstract: A 4?-demethylepipodophyllotoxin derivative of formula(III) having anti-tumor activity is provided. After the activation of hydroxyl in position C4 of 4?-demethylepipodophyllotoxin, tetramethylpyrazine is introduced by transamination to obtain the 4?-demethylepipodophyllotoxin derivative which is preferably used to inhibit gastric cancer line BGC-823.
    Type: Application
    Filed: April 22, 2011
    Publication date: February 14, 2013
    Applicant: HUBEI UNIVERSITY OF TECHNOLOGY
    Inventor: YaJie Tang